Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome
1 other identifier
interventional
6
1 country
1
Brief Summary
The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedStudy Start
First participant enrolled
February 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2025
CompletedAugust 11, 2025
April 1, 2025
2.2 years
September 15, 2022
August 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Preterm infant weight gain
To determine the relationship among sodium intake, bodily growth and the gut in preterm infants
8 weeks
Secondary Outcomes (1)
Microbiome
8 weeks
Study Arms (2)
Sodium algorithm
EXPERIMENTALStarting at 2 weeks of age, the sodium algorithm group will be started based on their sodium levels. This will be adjusted weekly based on weight gain and sodium levels.
Control
NO INTERVENTIONSubjects will be cared for by current protocols
Interventions
Infants will receive sodium and follow a sodium supplementation schedule or algorithm. This means that based on the sodium levels collected from the samples (stool and urine) they will receive an increase or maintain the same amount to help
Eligibility Criteria
You may qualify if:
- Birthweight \>500 grams and
- Gestational age at least 25 0/7weeks but less than 30 weeks.
- \<14 days of age at time of randomization
You may not qualify if:
- Non-English speaking parents
- Major congenital anomalies
- grade underlying renal dysfunction (serum creatinine \> 1.0 mg/dL or increase of \>0.3 mg/DL between any two consecutive measurements)
- any structural genitourinary criteria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's wisconsin
Milwaukee, Wisconsin, 53226, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey Segar, MD
Medical College of Wisconsin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 15, 2022
First Posted
September 21, 2022
Study Start
February 8, 2023
Primary Completion
April 14, 2025
Study Completion
April 14, 2025
Last Updated
August 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share